No differences in cortical fMRI activation were observed in patients with MGMT methylation, Ki-67 values, or different tumor grades, as well as between all these parameters of histopathological and molecular characterization and DTI microstructural alterations. The gene discussed is MKI67; the disease is neoplasm.